ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,287.30
0.00%
Dow Jones
44,910.65
0.42%
Gold vs US Dollar
2,630.50
-0.57%
Brent Oil
72.205
0.18%
Bitcoin
95,990.84
-1.31%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Cerevel Therapeutics Holdings Inc (CERE)

  7. Cerevel Therapeutics Holdings Inc (CERE) News

Cerevel Therapeutics (CERE)

Cerevel Therapeutics Holdings Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CERE
DateTimeSourceHeadlineSymbolCompany
12/08/202411:30Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:CERECerevel Therapeutics Holdings Inc
06/08/202404:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CERECerevel Therapeutics Holdings Inc
06/08/202404:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CERECerevel Therapeutics Holdings Inc
06/08/202404:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CERECerevel Therapeutics Holdings Inc
05/08/202420:38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CERECerevel Therapeutics Holdings Inc
05/08/202420:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CERECerevel Therapeutics Holdings Inc
05/08/202420:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CERECerevel Therapeutics Holdings Inc
05/08/202420:30Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:CERECerevel Therapeutics Holdings Inc
05/08/202420:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CERECerevel Therapeutics Holdings Inc
05/08/202420:26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CERECerevel Therapeutics Holdings Inc
05/08/202420:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CERECerevel Therapeutics Holdings Inc
01/08/202413:33Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:CERECerevel Therapeutics Holdings Inc
01/08/202413:32Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:CERECerevel Therapeutics Holdings Inc
01/08/202413:27Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:CERECerevel Therapeutics Holdings Inc
01/08/202413:26Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:CERECerevel Therapeutics Holdings Inc
01/08/202413:25Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:CERECerevel Therapeutics Holdings Inc
01/08/202413:24Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:CERECerevel Therapeutics Holdings Inc
01/08/202412:36Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CERECerevel Therapeutics Holdings Inc
01/08/202412:23PR Newswire (US)AbbVie Completes Acquisition of Cerevel TherapeuticsNASDAQ:CERECerevel Therapeutics Holdings Inc
08/05/202420:17Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CERECerevel Therapeutics Holdings Inc
18/04/202410:30GlobeNewswire Inc.Cerevel Therapeutics Announces Positive Topline Results for Tavapadon in Phase 3 Adjunctive Trial for People Living with Parkinson’s DiseaseNASDAQ:CERECerevel Therapeutics Holdings Inc
27/02/202421:02Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:CERECerevel Therapeutics Holdings Inc
16/02/202421:46Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CERECerevel Therapeutics Holdings Inc
09/02/202414:00Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:CERECerevel Therapeutics Holdings Inc
09/02/202400:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CERECerevel Therapeutics Holdings Inc
24/01/202413:30PR Newswire (US)Kuehn Law Encourages MDC, WAVD, NS and CERE Investors to Contact Law FirmNASDAQ:CERECerevel Therapeutics Holdings Inc
23/01/202422:51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CERECerevel Therapeutics Holdings Inc
23/01/202422:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CERECerevel Therapeutics Holdings Inc
23/01/202422:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CERECerevel Therapeutics Holdings Inc
23/01/202422:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CERECerevel Therapeutics Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:CERE

Your Recent History

LSE
CNR
Condor Gold
LSE
GBP
Global Petroleum
LSE
AAZ
Anglo Asian Mining
LSE
GDR
Genedrive
LSE
SEA
Seascape Energy Asia
LSE
BARC
Barclays
LSE
DEC
Diversified Energy
LSE
OMI
Orosur Mining
LSE
BOO
Boohoo
LSE
SUP
Supreme
LSE
QBT
Quantum Blockchain Techn...
LSE
ZED
Zenova
LSE
VAL
Valirx
LSE
MTL
Metals Exploration
LSE
GEX
Georgina Energy
LSE
POS
Plexus
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved

    BLACK FRIDAY

    ADVFN

    Celebrating 25 years Est 1999-2024

    Save up to 50%* for Gold Trader

    1 year 30%, 2 years 40% and *3 years 50%

    *Across 3 years £3655.44 only £1827.72